p53 癌症中的聚合:分子机制,功能障碍和向疗法
Asma Shah1, Sara K AlMarzooqi2, Sameer Mirza3
1Watson-Crick Centre for Molecular Medicine, Islamic University of Science and Technology, Awantipora, Kashmir, India.
Advances in protein chemistry and structural biology
|November 27, 2025
概括
瘤抑制剂p53在癌症中表现出类似的聚合,形成驱动瘤进展的粉样纤维. 准这些聚合物为癌症治疗提供了一个新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 神经退行性疾病 神经退行性疾病
背景情况:
- 瘤越来越多地被视为类似子的疾病.
- 瘤抑制剂p53在癌症中至关重要,其聚合现在被认为是一种病理机制.
- p53聚合有助于粉样纤维的形成,功能改变和瘤的进展.
研究的目的:
- 审查p53子类聚合在瘤中的结构和机制方面.
- 总结针对癌症治疗的p53聚合的治疗策略.
主要方法:
- 对关于p53结构,聚合和功能的现有文献的审查.
- 分析影响p53聚合的因素 (突变,异构体,环境).
- 针对p53聚合物的当前和新兴治疗方法的摘要.
主要成果:
- 通过各种机制,p53在瘤中形成病态的粉样纤维.
- p53聚合导致瘤抑制功能的丧失,并促进癌症.
- 包括小分子和在内的几种治疗策略正在开发中,以抑制p53聚合.
结论:
- p53聚合是癌症发展和进展的重要因素.
- 准p53粉样蛋白聚合物代表了癌症的一种有前途的新疗法.
- 需要进一步的研究,以充分阐明致病机制,并优化治疗干预措施.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
DNA Damage can Stall the Cell Cycle
9.9K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
DNA Damage Can Stall the Cell Cycle
3.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Negative Regulator Molecules
38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K


